Figure 1.
Comparison of GPI presence in different blood cell lineages from PNH patients. (A) Representative FLAER staining analysis on blood cell populations from patient 6, showing FLAER− (GPIneg) and FLAER+ (GPIpos) neutrophils (CD15+), NK cells (CD3−CD19−CD14−CD56+), and T cells (CD3+). Separate analyses for CD56bright and CD56dim NK cells are shown. (B) Bar graph depicts the fraction of GPIneg granulocytes for each patient. Patient samples are ordered by contribution of GPIneg cells to the neutrophil compartment starting with largest clone size. (C-E) Bar graphs depict the fraction of GPIneg cells in other lineages, (C) CD56bright NK cells, (D) CD56dim NK cells, and (E) CD3+ T cells. Patient number and CMV status (IgG+ or IgG−) are indicated. (F) Longitudinal analysis of the fraction of GPIneg cells in each lineage over time in patient 15. The x-axis indicates the time postdiagnosis and the y-axis the fraction of GPIneg cells. FSC, forward scatter.

Comparison of GPI presence in different blood cell lineages from PNH patients. (A) Representative FLAER staining analysis on blood cell populations from patient 6, showing FLAER (GPIneg) and FLAER+ (GPIpos) neutrophils (CD15+), NK cells (CD3CD19CD14CD56+), and T cells (CD3+). Separate analyses for CD56bright and CD56dim NK cells are shown. (B) Bar graph depicts the fraction of GPIneg granulocytes for each patient. Patient samples are ordered by contribution of GPIneg cells to the neutrophil compartment starting with largest clone size. (C-E) Bar graphs depict the fraction of GPIneg cells in other lineages, (C) CD56bright NK cells, (D) CD56dim NK cells, and (E) CD3+ T cells. Patient number and CMV status (IgG+ or IgG) are indicated. (F) Longitudinal analysis of the fraction of GPIneg cells in each lineage over time in patient 15. The x-axis indicates the time postdiagnosis and the y-axis the fraction of GPIneg cells. FSC, forward scatter.

Close Modal

or Create an Account

Close Modal
Close Modal